Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$37.4 - $44.52 $208,467 - $248,154
5,574 New
5,574 $226,000
Q3 2020

Nov 16, 2020

SELL
$122.47 - $213.56 $150,638 - $262,678
-1,230 Closed
0 $0
Q2 2020

Aug 17, 2020

SELL
$185.52 - $231.25 $57,511 - $71,687
-310 Reduced 20.13%
1,230 $243,000
Q1 2020

May 15, 2020

BUY
$143.0 - $274.03 $220,220 - $422,006
1,540 New
1,540 $302,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.9B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.